CERT - Certara Inc
Certara Inc Logo

CERT - Certara Inc

https://www.certara.com
Recent News
Powered by Alpha Vantage
Bullish
Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling - Certara ( NASDAQ:CERT )
Benzinga • 1 month, 1 week ago • score: 0.17
RADNOR, Pa., Aug. 04, 2025 ( GLOBE NEWSWIRE ) -- Certara, Inc., a global leader in biosimulation, today announced that the European Medicines Agency ( EMA ) has formally qualified the Simcyp® Simulator for use in regulatory submissions across the EU. Certara is the first company to receive EMA ...
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Certara Inc. provides software products and technology services to clients for biosimulation in drug discovery, preclinical and clinical research, regulatory filings, and market access. The company is headquartered in Princeton, New Jersey.

52W High
$15.69
52W Low
$8.63
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.43
Valuation
Fair
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
210.40
Forward P/E (<15 better)
21.05
EV/EBITDA (<8 favorable)
17.68
EV/Revenue (<3 favorable)
4.51
P/S (TTM) (<3 favorable)
4.17
P/B (<3 favorable)
1.58
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
2.51%
Institutions (25–75% balanced)
104.20%
Shares Outstanding
160,624,000
Float
120,227,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
405,755,000
Gross Profit (TTM)
248,066,000
EPS (TTM)
0.05
Profit Margin (>10% good)
0.02%
Operating Margin (TTM) (higher better)
0.05%
ROE (TTM) (>15% strong)
0.01%
EPS YoY (Quarterly) (>10% good)
-0.14
Revenue YoY (Quarterly) (>8% good)
0.12
Momentum
Value
N/A
Previous
N/A
Trend
—
Signal Cross
No cross
As of
—